Evotec SE's latest marketcap:
As of 07/21/2025, Evotec SE's market capitalization has reached $1.55 B. According to our data, Evotec SE is the 7472th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.55 B |
| Revenue (ttm) | 922.53 M |
| Net Income (ttm) | -242,251,732.8 |
| Shares Out | 177.6 M |
| EPS (ttm) | -1.37 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/13/2025 |
Evotec SE's yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/21/2025 | €1.32 B | $1.55 B | -8.86% | 7472 |
| 12/30/2024 | €1.45 B | $1.5 B | -61.41% | 6851 |
| 12/29/2023 | €3.77 B | $4.16 B | 39.63% | 3330 |
| 12/30/2022 | €2.7 B | $2.89 B | -63.78% | 4150 |
| 12/30/2021 | €7.44 B | $8.46 B | 50.39% | 2080 |
| 12/30/2020 | €4.95 B | $6.05 B | 42.55% | 2443 |
| 12/30/2019 | €3.47 B | $3.89 B | 35.76% | 2867 |
| 12/28/2018 | €2.56 B | $2.93 B | 29% | 3082 |
| 12/29/2017 | €1.98 B | $2.38 B | 101% | 4085 |
| 12/30/2016 | €986.44 M | $1.04 B | 78.91% | 6352 |
Company Profile
About Evotec SE
Evotec SE is a global drug discovery and development partner serving the pharmaceutical and biotechnology industries. The company focuses on creating innovative pharmaceutical products across a broad spectrum of therapeutic areas.
Therapeutic Areas
- Autoimmune diseases
- Cancer
- CNS diseases
- Diabetes
- Fibrosis
- Immunology
- Infectious diseases
- Kidney diseases
- Liver diseases
- Pain and inflammation
- Rare diseases
- Respiratory diseases
- Tuberculosis
- Women’s health
Key Collaborations
Evotec SE has established strategic partnerships with leading organizations, including:
- SK bioscience
- Carrick Therapeutics
- Bristol Myers Squibb
- Bayer
- Pfizer (for metabolic and infectious diseases)
- Dewpoint Therapeutics (biomolecular condensates research)
- CHDI Foundation, Inc.
- Sanofi/NIH
Company Background
Formerly known as Evotec AG, the company rebranded as Evotec SE in April 2019. Founded in 1993, Evotec SE is headquartered in Hamburg, Germany.
Frequently Asked Questions
-
What is Evotec SE's (ETR-EVT) current market cap?As of 07/21/2025, Evotec SE (including the parent company, if applicable) has an estimated market capitalization of $1.55 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Evotec SE (ETR-EVT) rank globally by market cap?Evotec SE global market capitalization ranking is approximately 7472 as of 07/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.